01.03.2002 | Basic/Clinical Science
A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis
Erschienen in: Journal of Cutaneous Medicine and Surgery | Ausgabe 2/2002
Einloggen, um Zugang zu erhalten